DPH Dechra Pharmaceuticals Plc

TIDMDPH 
 
 
AMENDMENT - this form replaces previous form released on 15/01/21 at 15:25 PM UK (London) time. 
 Correction made in Section 2, (a). 
                                                                                           FORM 8.3 
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY 
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 
Rule 8.3 of the Takeover Code (the "Code") 
 
 
1          KEY INFORMATION 
 
(a) Full name of discloser:                                       MELQART ASSET MANAGEMENT (UK) LTD 
(b) Owner or controller of interests and short positions 
disclosed, if different from 1(a):                                N/A 
The naming of nominee or vehicle companies is insufficient. For 
 a trust, the trustee(s), settlor and beneficiaries must be 
 named. 
(c) Name of offeror/offeree in relation to whose relevant 
securities this form relates:                                     Dechra Pharmaceuticals PLC 
Use a separate form for each offeror/offeree 
(d) If an exempt fund manager connected with an offeror/offeree, 
state this and specify identity of offeror/offeree:               N/A 
(e) Date position held/dealing undertaken:                        2024-01-12 
For an opening position disclosure, state the latest practicable 
 date prior to the disclosure 
(f) In addition to the company in 1(c) above, is the discloser 
making disclosures in respect of any other party to the offer?    No 
If it is a cash offer or possible cash offer, state "N/A" 
 
2          POSITIONS OF THE PERSON MAKING THE DISCLOSURE 
 
If there are positions or rights to subscribe to disclose in more than one class of relevant 
 securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each 
 additional class of relevant security. 
 
           Interests and short positions in the relevant securities of the offeror or offeree to 
(a)        which the disclosure relates following the dealing (if any) 
 
 
Class of relevant security:                          1p ordinary 
 
                                                     Interests                     Short positions 
                                                     Number       %                Number  % 
(1) Relevant securities owned and/or controlled: 
(2) Cash-settled derivatives:                        1,887,566    1.66% 
(3) Stock-settled derivatives (including options) 
 and agreements to purchase/sell: 
 
TOTAL:                                               1,887,566    1.66% 
 
All interests and all short positions should be disclosed. 
 
Details of any open stock-settled derivative positions (including traded options), or agreements to 
 purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). 
 
(b)        Rights to subscribe for new securities (including directors' and other employee options) 
 
Class of relevant security in relation to which 
 subscription right exists: 
Details, including nature of the rights concerned 
 and relevant percentages: 
 
 
3          DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE 
 
Where there have been dealings in more than one class of relevant securities of the offeror or 
 offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class 
 of relevant security dealt in. 
 
The currency of all prices and other monetary amounts should be stated. 
 
(a)        Purchases and sales 
 
 
Class of relevant                                                                  Price per unit 
security                 Purchase/sale               Number of securities          (GBp) 
 
 
 
(b)        Cash-settled derivative transactions 
 
                                                                                           Price per 
Class of relevant        Product                                  Number of reference      unit 
security                 description   Nature of dealing          securities               (GBp) 
                                       e.g. opening/closing a 
                                       long/short position, 
                                       increasing/reducing a 
                         e.g. CFD      long/short position 
                                       decreasing a long 
1p ordinary              CFD           position                   -38,760                  3865 GBp 
 
(c)        Stock-settled derivative transactions (including options) 
 
(i)        Writing, selling, purchasing or varying 
 
                         Writing,      Number of                                           Option 
           Product       purchasing,   securities                                          money 
Class of   description   selling,      to which      Exercise                              paid/ 
relevant   e.g. call     varying       option        price per                     Expiry  received 
security   option        etc.          relates       unit         Type             date    per unit 
                                                                  e.g. American, 
                                                                  European etc. 
 
 
(ii)       Exercise 
 
Class of                               Exercising/ 
relevant                               exercised     Number of    Exercise price 
security   Product description         against       securities   per unit 
 e.g. call option 
 
 
 
(d)        Other dealings (including subscribing for new securities) 
 
Class of                                                          Price per unit 
relevant                                                          (if 
security   Nature of dealing           Details                    applicable) 
 e.g. subscription, 
  conversion 
 
 
 
 
4          OTHER INFORMATION 
 
(a)        Indemnity and other dealing arrangements 
 
Details of any indemnity or option arrangement, or any agreement or understanding, formal or 
 informal, relating to relevant securities which may be an inducement to deal or refrain from dealing 
 entered into by the person making the disclosure and any party to the offer or any person acting in 
 concert with a party to the offer: 
Irrevocable commitments and letters of intent should not be included. If there are no such 
 agreements, arrangements or understandings, state "none" 
 
None 
 
 
(b)        Agreements, arrangements or understandings relating to options or derivatives 
 
Details of any agreement, arrangement or understanding, formal or informal, between the person making 
 the disclosure and any other person relating to: 
(i) the voting rights of any relevant securities under any option; or 
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any 
 derivative is referenced: 
If there are no such agreements, arrangements or understandings, state "none" 
 
None 
 
 
(c)        Attachments 
 
Is a Supplemental Form 8 (Open Positions) attached?                                No 
 
 
Date of disclosure:                                  2024-01-15 
Contact name:                                        Ben Sharp 
Telephone number:                                    +44 (0)20 3826 4493 
 
Public disclosures under Rule 8 of the Code must be made to a Regulatory 
Information Service. 
 
The Panel's Market Surveillance Unit is available for consultation in relation 
to the Code's disclosure requirements on +44 (0)20 7638 0129. 
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk. 
 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240115388349/en/

 
    CONTACT: 

Melqart Asset Management

 
    SOURCE: Melqart Asset Management 
Copyright Business Wire 2024 
 

(END) Dow Jones Newswires

January 15, 2024 10:40 ET (15:40 GMT)

Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Mar 2024 to Apr 2024

Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2023 to Apr 2024